SLC1A5 and cancer: L-g-glutamyl-p-nitroanilide is an inhibitor of SLC1A5 that leads to GLN starvation in cells and inhibits GLN-dependent mTOR activation, thus suppressing cancer progression [9, 63, 110–112].